Newsletter | January 5, 2026

01.05.26 -- STREAM Edition: Establishing Realistic Development Timelines With A CDMO

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

Webinar | Adare Pharma Solutions

Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

Accelerating Early Phase Biologics From The Clinic To Commercialization

Webinar | Abzena

Strategic planning in early-phase biologics accelerates clinical progress, reduces risk, and lays the groundwork for scalable, compliant manufacturing and successful commercialization.

MilliporeSigma Capacity Update October 2025: Large Molecule

Video | MilliporeSigma

Our global facilities are built to guide you when you’re ready to scale, providing expertise and infrastructure to power your mRNA journey from early discovery through development and global commercialization.

Navigating Regulatory Expectations For Injectable Packaging

Webinar | West Pharmaceutical Services, Inc.

Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

Establishing Realistic Development Timelines With A CDMO

Video | Outsourced Pharma

This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right," details how sponsors can build realistic development and manufacturing timelines with CDMOs by combining complete transparency, upfront risk assessment, phase-based planning, and shared Gantt-style project dashboards instead of rushing straight from research to GMP, featuring panelist Vadim Klyushnichenko, VP Bio/Pharmaceutical Development & Quality at the Calibr-Skaggs Institute for Innovative Medicines.

Every Medicine Has A Story. We Help You Write Yours.

Video | SK pharmteco

We are a leading global CDMO with a network of cGMP facilities in key markets. From early development to commercial scale, we handle the manufacturing and testing that help your therapies take the next step.

Hear From The Experts: LNPs Driving The Future Of Cell Therapy

Webinar | Cytiva

Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.